SecBot SecBot

QCLS

Q/C TECHNOLOGIES, INC.
Nasdaq· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0001321834 Biotech & Drug Discovery
$0.4500 −0.02 (−4.86%)
Oct 26 4:00 PM ET · prev $0.4730
Market cap
$3.9M
Nano cap
Next earnings
Nov 17
in 21 days
1 year
−88.3%
from $3.84 · Oct 28
30 days
−46.0%
from $0.8330
52-week range
$0.4410–6.92
−93% from high · low Sep 15
Avg volume 20D
644.8K
Sep 30 spike 7.81M
Short interest
997.4K
≈12.2% of shares · +5.2%
Days to cover
3.6
at average volume
Insider net
+$5.5K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 17, 2026
Strongest NEUTRAL Q/C Technologies announced a collaboration with Sandia National Laboratories' Center for Integrated…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $5.5K at an average $3.15. No open-market sales. Price is 86% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 5 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest +5.2% to 997.4K shares. 3.6 days to cover, ≈12.2% of shares.

  • TrendDOWNTREND

    65% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Sep 30.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED115,031$448.6K
JANE STREET GROUP, LLCTRIM87,241$340.2K
GEODE CAPITAL MANAGEMENT, LLCADD70,682$275.7K
HRT FINANCIAL LPDOUBLED50,373$196.0K
VANGUARD FIDUCIARY TRUST CODOUBLED43,053$167.9K
STATE STREET CORPADD25,305$98.7K
JANE STREET GROUP, LLCDOUBLED126,188$435.3K
UBS Group AGDOUBLED77,989$269.1K

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 Press
Q/C Technologies announced a collaboration with Sandia National Laboratories' Center for Integrated Nanotechnologies…
Impact 3/10
Oct 1, 2026 Contract
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
Collaboration advances Q/C Technologies’ optical processing unit initiative for AI inference through
Oct 1, 2026 Insider
Silverman Joshua was granted 77,390 shares
Executive Chairman
Sep 30, 2026 Press
Q/C Technologies announced a collaboration with Sandia National Laboratories' Center for Integrated Nanotechnologies…
Impact 3/10
Sep 18, 2026 SEC
Q/C Technologies appointed Yossef Ehrlichman as Chief Technology Officer, promoted from Founding Manager of PIC…
8-K — Impact 3/10
Jul 10, 2026 Insider
Silverman Joshua was granted 16,620 shares
Executive Chairman
Jul 2, 2026 SEC
Q/C Technologies terminated its crypto-mining license agreement with LightSolver and is pivoting entirely to an…
8-K — Impact 4/10
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — DOUBLED
115,031 shares ($448.6K)

Insider ledger

Form 4
$5.5K
bought · 1 insider
$0
sold · 0 insiders
−85.7%
vs their $3.15 cost
DateInsiderTypeValue
Oct 1, 2026
Silverman Joshua
Executive Chairman
AWARD77,390 sh
Jul 10, 2026
Silverman Joshua
Executive Chairman
AWARD16,620 sh
Apr 13, 2026
Silverman Joshua
Executive Chairman
AWARD100,000 sh
Apr 13, 2026
Silverman Joshua
Executive Chairman
AWARD16,806 sh
Apr 13, 2026
Voss Chelsea Sierra
Director
AWARD50,000 sh
Apr 13, 2026
Friscia Stephen
Director
AWARD50,000 sh
Apr 13, 2026
Glass Mitchell
Chief Medical Officer
AWARD50,000 sh
Apr 13, 2026
Silverman Joshua
Executive Chairman
AWARD162,162 sh

Earnings setup

Estimates
Nov 17
reports in 21 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
997,351
shares short
+5.2%
vs prior settlement
3.6
days to cover
≈12.2%
of shares outstanding
Trading halts
Sep 16, 2026Volatility PauseResumed
Sep 16, 2026Volatility PauseResumed
Sep 16, 2026Volatility PauseResumed
Sep 16, 2026Volatility PauseResumed
Sep 16, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
QCLS Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Oct 1, 2026
Contract
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
Collaboration advances Q/C Technologies’ optical processing unit initiative for AI inference through nanophotonics research at Sandia’s Center for…
Sep 30, 2026
Contract
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
Collaboration advances Q/C Technologies’ optical processing unit initiative for AI inference through nanophotonics research at Sandia’s Center for…
Sep 16, 2026
Trading halt
Halt Resumed: QCLS — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-16T17:59:24.000Z | Resumed 2026-09-16T18:04:24.000Z
Sep 16, 2026
Trading halt
Trading Halt: QCLS — LUDP (Volatility Trading Pause)
Q/C Tech Inc Cmn Stk | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 16, 2026
Trading halt
Halt Resumed: QCLS — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-16T17:53:41.000Z | Resumed 2026-09-16T17:58:41.000Z
Reddit
Recent posts
r/pennystocks Neutral 28d ago
www.hotstocktobuytoday.com MUST READ!!!!! $QCLS
1 upvotes · 0 comments
r/pennystocks Bullish 28d ago
$QCLS this will easily Hit $3.00 Raredva very strong Buy 💪 and hold Tight , Big institutions buys coming in now this means triole your money! Easy
1 upvotes · 0 comments
All social signals and their track records

SecBot reports

3 filings · 2 press releases · 0 bullish · 0 bearish · 3 neutral
All QCLS filing & press-release reports (5)